Skip to content
10-Q

Quarterly Report

Protea Biosciences Group, Inc.

0001144204-17-028582

← back to feed
Filed
May 19, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2017 · May 18, 2017 215.15M sh
Cash And Equivalents Q1 2017 · Mar 31, 2017 $15.53K
Cash And Equivalents Q1 2017 · Dec 31, 2016 $78.72K
Cash And Equivalents Q1 2017 · Mar 31, 2016 $0
Cash And Equivalents Q1 2017 · Dec 31, 2015 $6.45K
Stockholders Equity Q1 2017 · Mar 31, 2017 −$16.42M
Stockholders Equity Q1 2017 · Dec 31, 2016 −$14.11M
Current Liabilities Q1 2017 · Mar 31, 2017 $17.24M
Current Liabilities Q1 2017 · Dec 31, 2016 $15.55M
Current Assets Q1 2017 · Mar 31, 2017 $295.68K
Current Assets Q1 2017 · Dec 31, 2016 $728.92K
Total Assets Q1 2017 · Mar 31, 2017 $2.65M
Total Assets Q1 2017 · Dec 31, 2016 $3.21M
Sga Expense Q1 2017 · Mar 31, 2017 $1.5M
Sga Expense Q1 2017 · Mar 31, 2016 $1.6M
Rd Expense Q1 2017 · Mar 31, 2017 $128.94K
Rd Expense Q1 2017 · Mar 31, 2016 $232.61K
Net Income Q1 2017 · Mar 31, 2017 −$5.86M
Net Income Q1 2017 · Mar 31, 2016 −$1.09M
Operating Income Q1 2017 · Mar 31, 2017 −$1.56M
Operating Income Q1 2017 · Mar 31, 2016 −$1.57M
Gross Profit Q1 2017 · Mar 31, 2017 $67.44K
Gross Profit Q1 2017 · Mar 31, 2016 $270.96K
Cost Of Revenue Q1 2017 · Mar 31, 2017 $287.4K
Cost Of Revenue Q1 2017 · Mar 31, 2016 $204.38K